Search Within

Shanu Modi

  1. "Surgery"
Formats
  1. Meeting Abstract (11)
  2. Journal Article (9)
Groups
  1. Breast Medicine Service (20)
  2. Department of Medicine (20)
  3. Solid Tumor Oncology Division (20)
  4. Surgery (20)
  5. Biostatistics Service (13)
  6. Epidemiology and Biostatistics (13)

More Groups

People
  1. Sujata Patil (8)
  2. Andrew Seidman (7)
  3. Clifford Hudis (7)
  4. Larry Norton (7)
  5. Sarat Chandarlapaty (7)
  6. Chau Dang (6)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2022 (2)
  4. 2021 (1)
  5. 2019 (2)
  6. 2018 (1)

More Years

Publications
  1. Cancer Research (5)
  2. Journal of Clinical Oncology (4)
  3. Clinical Cancer Research (2)
  4. npj Breast Cancer (2)
  5. Annals of Oncology (1)
  6. Annals of Surgical Oncology (1)

More Publications

Publishers
  1. American Association for Cancer Research (8)
  2. American Society of Clinical Oncology (4)
  3. Nature Publishing Group (3)
  4. Oxford University Press (2)
  5. Elsevier Inc. (1)
  6. Lippincott Williams & Wilkins (1)

More Publishers

Results (20)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Biomarkers that predict sensitivity to heat shock protein 90 inhibitors
    Journal Article

    Jhaveri, K.; Chandarlapaty, S.; Iyengar, N.; Morris, P. G.; Corben, A. D.; Patil, S.; Akram, M.; Towers, R.; Sakr, R. A.; King, T. A.; more...
    Clinical Breast Cancer (2016)

    Fulltext@MSK | Save
  • The effect of molecular subtype and residual disease on locoregional recurrence in breast cancer patients treated with neoadjuvant chemotherapy and postmastectomy radiation
    Journal Article

    Yang, T. J.; Morrow, M.; Modi, S.; Zhang, Z.; Krause, K.; Siu, C.; McCormick, B.; Powell, S. N.; Ho, A. Y.
    Annals of Surgical Oncology (2015)

    Fulltext@MSK | Save
  • A phase I/II study of neratinib plus temsirolimus in HER2+ metastatic breast cancer reveals ongoing HER2 pathway dependence in many patients despite several lines of HER2 targeted therapy
    Meeting Abstract

    Gajria, D.; Modi, S.; Saura, C.; Sakr, R.; Solano, K.; Won, H.; Pannu, H.; Patil, S.; Lake, D.; Traina, T.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Does biologic subtype and pathologic response after neoadjuvant chemotherapy predict locoregional recurrence?
    Meeting Abstract

    Yang, T. J.; Morrow, M.; Modi, S.; Krause, K.; Siu, C.; Gupta, G. P.; McCormick, B.; Powell, S. N.; Ho, A. Y.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Biomarkers that predict sensitivity to heat shock protein 90 inhibitors (HSP90i)
    Meeting Abstract

    Jhaveri, K. L.; Iyengar, N. M.; Corben, A.; Patil, S.; Akram, M.; Towers, R.; Sakr, R.; Hudis, C.; King, T. A.; Rosen, N.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Tolerability and efficacy of targeting both mTOR and HER2 signaling in trastuzumab-refractory HER2+ metastatic breast cancer
    Meeting Abstract

    Gajria, D.; King, T.; Pannu, H.; Sakr, R.; Modi, S.; Drullinsky, P.; Syldor, A.; Patil, S.; Seidman, A.; Norton, L.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Frequent mutational activation of the PI3K-AKT pathway in trastuzumab-resistant breast cancer
    Journal Article

    Chandarlapaty, S.; Sakr, R. A.; Giri, D.; Patil, S.; Heguy, A.; Morrow, M.; Modi, S.; Norton, L.; Rosen, N.; Hudis, C.; more...
    Clinical Cancer Research (2012)

    Fulltext@MSK | Save
  • Combined inhibition of mTORC1 with temsirolimus and HER2 with neratinib: A phase I/II study in patients with metastatic HER2-amplified or triple-negative breast cancer
    Meeting Abstract

    Gajria, D.; King, T.; Pannu, H.; Sakr, R.; Seidman, A. D.; Modi, S.; Dickler, M.; Drullinsky, P.; Syldor, A.; Sujata, P.; more...
    Cancer Research (2011)

    Fulltext@MSK | Save
  • A feasibility study of bevacizumab plus dose-dense doxorubicin- cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel in early-stage breast cancer
    Journal Article

    Mcarthur, H. L.; Rugo, H.; Nulsen, B.; Hawks, L.; Grothusen, J.; Melisko, M.; Moasser, M.; Paulson, M.; Traina, T.; Patil, S.; more...
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save
  • Pharmacokinetics (PK) of trastuzumab-DM1 (T-DM1) and paclitaxel (T) in patients with HER2-positive locally advanced or metastatic breast cancer (MBC) previously treated with a trastuzumab-containing regimen
    Meeting Abstract

    Lu, D.; Krop, I.; Modi, S.; Elias, A.; LoRusso, P.; Huang, J.; Lu, M.; Girish, S.
    Cancer Research (2010)

    Fulltext@MSK | Save